Opthea Limited Sponsored ADROpthea Limited Sponsored ADROpthea Limited Sponsored ADR

Opthea Limited Sponsored ADR

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪487.32 M‬USD
−1.06USD
‪−162.51 M‬USD
‪24.96 K‬USD
Beta (1Y)
3.09

About Opthea Limited


CEO
Jeremy Max Levin
Website
Headquarters
Melbourne
Founded
1984
ISIN
US68386J2087
FIGI
BBG001QSYT51
Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. It operates through the United States and Australia geographical segments. The company was founded by Dr. Megan Baldwin on October 17, 1984, and is headquartered in Melbourne, Australia.

Check out other big names from the same industry as OPT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.